Rationale and Characteristics of the Parent Compound
Nicotinic acid itself has the property of dilating blood vessels both peripherally and in the brain. However, its main drawback is poor patient tolerance due to pronounced adverse effects. For this reason, in clinical practice involving cerebral blood flow disorders, modified derivatives are preferred because they retain the necessary therapeutic efficacy while being significantly better tolerated.
Xanthinol Nicotinate
This is a combination drug whose chemical structure combines elements of nicotinic acid and theophylline.
Pharmacodynamic properties:
- Vasodilation: dilates peripheral and cerebral blood vessels.
- Hemodynamics: improves blood flow in both vascular beds.
- Metabolic Effect: reduces the severity of cerebral hypoxia.
- Rheology: exerts a moderate antiplatelet effect, decreasing platelet aggregation tendency.
The main indication for prescription is peripheral and cerebral circulatory disorders developing against the background of atherosclerosis.
Nicotinoyl-GABA (Picamilon)
This agent is classified as a GABA derivative (gamma-aminobutyric acid). Its chemical molecule combines fragments of GABA and nicotinic acid. The main pharmacological feature of picamilon is its selective (preferential) dilation of cerebral blood vessels, making it an important tool in managing cerebrovascular disorders.